BraveWorms
Begin intake

References

The published guidance behind every consultation.

Guidelines

  1. Centers for Disease Control and Prevention. Guidance for Overseas Presumptive Treatment of Strongyloidiasis, Schistosomiasis, and Soil-Transmitted Helminth Infections for Refugees Resettling to the United States. U.S. Department of Health and Human Services, updated January 30, 2025.
  2. White AC Jr, et al. Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clinical Infectious Diseases, 2018;66(8):e49 to e75.
  3. World Health Organization. WHO guideline on control and elimination of human schistosomiasis and preventive chemotherapy for strongyloidiasis. World Health Organization, 2024.

Randomized trials and primary clinical literature

  1. Buonfrate D, et al. Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial. The Lancet Infectious Diseases, 2019;19:1181 to 1190.
  2. Swanson SJ, Phares CR, Mamo B, Smith KE, Cetron MS, Stauffer WM. Albendazole therapy and enteric parasites in United States bound refugees. New England Journal of Medicine, 2012;366(16):1498 to 1507.
  3. Mitchell T, et al. Presumptive treatment with albendazole and ivermectin for Thailand-Burma border refugees. American Journal of Tropical Medicine and Hygiene, 2018.

Public health research

  1. Hotez PJ. Neglected parasitic infections and poverty in the United States. PLOS Neglected Tropical Diseases, 2014.
  2. Hotez PJ. The rise of neglected tropical diseases in the new Texas. PLOS Neglected Tropical Diseases, 2018.

References to the Centers for Disease Control and Prevention, the Infectious Diseases Society of America, the American Society of Tropical Medicine and Hygiene, the World Health Organization, and other public health bodies on this site are provided for educational context. BraveWorms is not affiliated with, endorsed by, or sponsored by any cited organization or publication.